Arginine demethylation is catalysed by a subset of JmjC histone lysine demethylases by Walport LJ et al.
ARTICLE
Received 29 Nov 2015 | Accepted 17 May 2016 | Published 23 Jun 2016
Arginine demethylation is catalysed by a subset
of JmjC histone lysine demethylases
Louise J. Walport1, Richard J. Hopkinson1, Rasheduzzaman Chowdhury1, Rachel Schiller1, Wei Ge1,
Akane Kawamura1,2 & Christopher J. Schofield1
While the oxygen-dependent reversal of lysine Ne-methylation is well established, the
existence of bona fide No-methylarginine demethylases (RDMs) is controversial. Lysine
demethylation, as catalysed by two families of lysine demethylases (the flavin-dependent
KDM1 enzymes and the 2-oxoglutarate- and oxygen-dependent JmjC KDMs, respectively),
proceeds via oxidation of the N-methyl group, resulting in the release of formaldehyde. Here
we report detailed biochemical studies clearly demonstrating that, in purified form, a subset
of JmjC KDMs can also act as RDMs, both on histone and non-histone fragments, resulting in
formaldehyde release. RDM catalysis is studied using peptides of wild-type sequences known
to be arginine-methylated and sequences in which the KDM’s methylated target lysine is
substituted for a methylated arginine. Notably, the preferred sequence requirements for KDM
and RDM activity vary even with the same JmjC enzymes. The demonstration of RDM activity
by isolated JmjC enzymes will stimulate efforts to detect biologically relevant RDM activity.
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P
ost-translational modifications, which vastly increase the
size of the functional proteome, play central roles in
numerous cellular processes, including enzyme catalysis,
protein–protein interactions and gene regulation1. Modifications
to histones, which are especially prevalent on the N-terminal tail
of histone H3, include Ne-acetylation and ubiquitination of lysine
residues, phosphorylation of serine and threonine residues, and
Ne/o-methylation of lysine and arginine residues2. Coupled with
other factors, these modifications regulate the sets of genes that
are transcribed in a time- and context-dependent manner. While
lysine acetylation is usually transcriptionally activating, arginine-
and lysine methylation can be either activating or repressive,
depending on the site and extent of methylation.
Arginine/lysine methylation is catalysed by S-adenosyl-methio-
nine-dependent methyltransferases (protein arginine methyl-
transferases, PRMTs, and lysine methyltransferases, KMTs,
respectively)3. Although for many years N-methylation was
thought to be a stable, irreversible modification, the reversal
of lysine methylation is now well established. Two families
of histone Ne-methyllysine demethylases (KDMs) have been
identified; the flavin-dependent KDM1s (lysine-specific
demethylase) and the Fe(II)- and 2-oxoglutarate (2OG)-
dependent JmjC-domain-containing enzymes. Both families of
KDMs operate via methyl-group oxidizing mechanisms that
result in the co-production of formaldehyde4. Lysine
methylation/demethylation can thus occur on a timescale of
only two enzyme-catalysed steps, that is, has the potential to be
highly dynamic.
In contrast to lysine methylation, the extent to which arginine
methylation is dynamic is much less clear. Arginine residues
undergo PRMT-catalysed methylation on their terminal
guanidine nitrogens to give monomethyl (MMA/Rme), and
symmetric (SDMA/Rme2s) and asymmetric (ADMA/Rme2a)
dimethylated forms5. The peptidyl-arginine deiminases (PADs)
catalyse the hydrolysis of the guanidino arginine side chain to
the urea group of citrulline. Both PAD2 and PAD4 catalyse
citrulline formation at multiple positions on histone tails6. In the
case of PAD4, this activity has also been reported on
monomethylarginine residues7, although evidence that this
activity occurs in an in vivo setting remains limited8. In either
case, demethylimination is not a ‘true’ demethylation reaction—it
removes but does not reverse No-methylation. Neutral citrulline
is produced, which has considerably different chemical properties
compared to unmethylated arginine. One 2OG oxygenase,
JMJD6, has been reported to catalyse methylarginine
demethylation of histone H3/H4 residues9. Some subsequent
reports have not reproduced these observations, and JMJD6 has
also been assigned as a lysine C-5 hydroxylase acting on mRNA
splicing-regulatory proteins, and potentially histone proteins10–12.
Other recent reports have identified further arginine demethylation
activity by JMJD6 on histone and non-histone substrates13–16;
however, the biochemical evidence for methylarginine
demethylation by JMJD6 is not unequivocal17.
Despite the controversial history as potential methylarginine
demethylases (RDMs), the 2OG oxygenases represent good
candidates for such reactions because of the broad spectrum of
oxidative reactions that they catalyse. Some JmjC oxygenases
catalyse hydroxylation of lysine residues to give stable hydro-
xylated products18. Arginine demethylation could occur via
oxidation of the arginine No-methyl group and concomitant
loss of formaldehyde in a reaction analogous to that of lysine
demethylation (Fig. 1a,b). In a recent study we found that the
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Figure 1 | Mechanism of lysine and arginine demethylation. (a) JmjC lysine demethylases (KDM2–7 subfamilies) catalyse oxidative decarboxylation of
2OG to form succinate, carbon dioxide and a reactive iron(IV)-oxo intermediate; this intermediate then facilitates hydroxylation of the lysine Ne-methyl
group to form an unstable hemiaminal. Fragmentation of the hemiaminal releases formaldehyde and the unmethylated lysine residue. (b) Proposed
mechanism for JmjC-catalysed arginine demethylation. (c) Hydroxylation of the N-methyl,N-isopropyllysine derivative is catalysed by various JmjC KDMs
at a position analogous to that required for demethylation of asymmetrically dimethylated arginine residues. Methyl groups are bold red lines, dashed
arrows represent proposed reactions and HCHO is formaldehyde. Each JmjC KDM/RDM/oxidation reaction is coupled to the conversion of 2OG and
oxygen to carbon dioxide and succinate.
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JmjC KDMs can catalyse oxidation of Ne-alkyl groups other than
methyl groups, including oxidation reactions on isopropyl groups
at a position equivalent to that required for oxidation of a
No-methylarginine group (Fig. 1c)19. Here we report systematic
studies on the potential of the catalytic domains of representative
human JmjC enzymes to catalyse No-methylarginine
demethylation. The results clearly demonstrate that some, but
not all, purified JmjC KDMs can act as RDMs.
Results
JmjC enzymes have RDM activity. To test whether the catalytic
domains of the JmjC KDMs can act as RDMs, we produced
truncated recombinant proteins containing the catalytic domains
of representatives of the six identified human JmjC KDM
subfamilies (KDM2A, KDM3A, KDM4E, KDM5C, KDM6B and
PHF8 (also known as KDM7B), Fig. 2a)20,21. The representative
JmjC KDMs were tested for in vitro demethylation activity with
synthetic fragment sequences of the histone H3 tail with mono-
and asymmetric/symmetric dimethylated arginine residues
replacing the Ne-methylated lysine residues known to be
demethylated in established substrates for each JmjC KDM
(Supplementary Table 1). The corresponding ‘wild-type’ peptides
with the naturally positioned Ne-methylated lysine residues were
used as positive controls. Reactions were initially analysed using
MALDI-TOF mass spectrometry (MS) to test for demethylation
(observed as a  14Da mass shift).
For KDM2A and PHF8, demethylation was observed only for
the characterized lysine substrates (Supplementary Figs 1 and 2),
that is, no RDM activity was detected. Interestingly, however, in
addition to demethylation of the characterized lysine substrates,
evidence for demethylation of both asymmetric and symmetric
dimethyl- and monomethylarginine residues was accrued by MS
for KDM3A, KDM4E, KDM5C and KDM6B (Fig. 2b and
Supplementary Figs 3–6), that is, product peptide spectra
manifested mass shifts of  14Da (and in some cases  28Da,
corresponding to the loss of two methyl groups) relative to the
methylated substrate residue. Under our incubation conditions,
such mass shifts were only observed in the mass spectra of
reactions in the presence of enzyme. KDM3A, KDM4E and
KDM5C catalysed demethylation of both symmetric and
asymmetric dimethylarginine residues to give a mixture of both
the monomethylated and unmethylated arginine residues. At least
under the tested conditions, however, we observed that KDM6B
only catalyses a single demethylation of asymmetric dimethy-
larginine to the monomethylated species. Within our limits
of detection, no activity was observed for KDM6B and the
tested peptides containing monomethylarginine or symmetric
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dimethylarginine (Supplementary Fig. 6a). Interestingly, when the
KDM6B substrate was extended from 15 to 21 residues, a double
demethylation reaction to the unmethylated arginine residue was
observed in the MALDI MS of reactions containing KDM6B
(Supplementary Fig. 6b). As expected for a 2OG oxygenase-
catalysed reaction, demethylation by KDM6B required the
presence of the Fe(II) cofactor and 2OG co-substrate (Fig. 3a).
In order to validate the MS-based results, we used NMR
spectroscopy to follow KDM6B-catalysed demethylation of the
15- and 21-residue H3K27Rme2a peptides. Immediately after
initiation of the reaction, the samples containing KDM6B, with
either the 15- or 21-residue peptide substrate and cofactors/
co-substrates, were transferred to NMR tubes and then subjected
to 1H NMR (700MHz) analyses (Fig. 3b and Supplementary
Fig. 7a). In both samples, conversion of 2OG to succinate was
evidenced by reduction of the 1H resonance at dH 2.4 p.p.m.
(corresponding to the protons attached to C4 of 2OG) with
concomitant emergence of a 1H resonance at dH 2.3 p.p.m.
(corresponding to the methylene protons of succinate). An
additional singlet resonance at dH 2.8 p.p.m. was also observed to
increase in intensity during the analyses; this was assigned to the
N-methyl protons of the monomethylarginine product based on
1H and 13C chemical shift analyses (dC 27.5 p.p.m., as determined
by 1H-13C-HSQC analysis of the sample with the 15-residue
peptide, Fig. 3b and Supplementary Fig. 7b). Quantitative
analyses on the sample with the 21-residue peptide revealed a
faster rate of succinate production relative to the rate of peptide
demethylation, indicating some uncoupling of 2OG and peptide
oxidation (that is, some conversion of 2OG to succinate without
concomitant oxidation of the peptide methyl group). The degree
of 2OG oxidation was greater in the presence of peptide than
without peptide, suggesting that binding of the peptide to
KDM6B stimulates 2OG oxidation but does not always
necessarily lead to methyl group oxidation (Fig. 3c and
Supplementary Fig. 7c). This ‘uncoupling’ of 2OG oxidation
and peptide demethylation is well precedented for 2OG
oxygenases, although it is less pronounced during KDM4E-
catalysed demethylation of methyllysine peptides22. Addition of
the formaldehyde-trapping reagent dimedone to the NMR
reaction mixture in the presence of the 15 residue peptide
resulted in the emergence of new 1H resonances, which were
assigned to two dimedone–formaldehyde adducts (Fig. 3d). These
adducts have been previously observed to form upon incubation
of dimedone with formaldehyde released during JmjC KDM-
catalysed demethylation, and therefore imply that KDM6B-
catalysed methylarginine demethylation follows a similar
mechanism to that for methyllysine demethylation (that is,
methyl group oxidation to release formaldehyde)22. The
combined MS and NMR results thus reveal that some JmjC
oxygenases can catalyse No-methyl arginine demethylation.
Preliminary kinetic parameters for selected methylarginine
variant peptides were determined using a formaldehyde
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Figure 3 | The mechanisms of arginine and lysine demethylation are similar. (a) The arginine demethylation reaction of KDM6B requires both 2OG and
Fe(II) for active demethylation. The degree of arginine demethylation of H3(14–34)K27Rme2a catalysed by KDM6B was quantified by MALDI-TOF mass
spectrometry. Data show the mean±s.e.m. (b) 1H NMR analyses of KDM6B-catalysed arginine demethylation. The 1H spectra are of a reaction mixture
containing KDM6B (9 mM), H3(14–34)K27Rme2a peptide (1mM), 2OG (500mM), ascorbate (1mM) and iron(II) (100mM) after 7min (blue) and 20min
(red) at 298K. The resonance corresponding to the methyl group of monomethylated arginine (Rme) is highlighted. (c) Graphs showing the degree of
succinate production and peptide demethylation of H3(14–34)K27Rme2a catalysed by KDM6B as quantified by 1H NMR (700MHz). (d) Detection of
formaldehyde release during KDM6B-catalysed arginine demethylation. Dimedone reacts with formaldehyde in aqueous solution to form stable adducts
that are detectable using 1H NMR (insert, the formaldehyde-derived carbons in the adducts are highlighted red). Incubation of a reaction mixture containing
KDM6B (6.5mM), H3(18–30)K27Rme2a peptide (1mM), 2OG (4mM), ascorbate (1mM) and iron(II) (100mM) and dimedone (667mM) revealed the
formation of two dimedone adducts using 1H NMR (700MHz). Protons responsible for each peak are shown in red.
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dehydrogenase-coupled demethylation assay (Table 1)23.
In the case of KDM6B, the methylated arginine peptide
probably binds more weakly (as judged by KM values)
in the active site than its methylated lysine analogue (KM
676.3±118.3 versus 6.7±0.6 mM). Interestingly, however, the kcat
value for the arginine peptide was higher than that for the
analogous lysine peptide (kcat 28.8 10 3±3.6 10 3 versus
11.7 10 3±0.1 10 3 s 1), suggesting that in the context of
a tighter binding substrate (for example, a protein rather than the
peptides tested here) it is possible that arginine demethylation by
KDM6B is as efficient as, or favoured relative to, lysine
demethylation. For KDM5C, the rate of asymmetric
dimethylarginine demethylation was also found to be of similar
levels to that of lysine demethylation (kcat 41.2±3.5 versus
67.1±10.3 s 1), while for KDM3A and KDM4E both the rate of
demethylation and binding constants were found to be
considerably lower for the arginine peptides than the analogous
lysine peptides (Table 1). KDM4E appears to bind to the peptide
containing symmetric arginine less well than the asymmetric
residue (KM 101.1±11.0 versus 66.0±5.0 mM), but has a faster
maximal turnover rate for the symmetric peptide (kcat
8.7 10 3±0.3 10 3 versus 4.6 10 3±0.7 10 3 s 1),
resulting in similar kcat/KM values. All kcat values were lower
and KM were higher than those for the established H3K9me3
peptide substrate for KDM4E. The monomethylated H3K9Rme
peptide had a higher KM value than both the dimethylated
peptides, and displayed the lowest turnover rate
(kcat 2.7 10 3±0.2 10 3 s 1. Note that monomethylated
lysine residues are poor substrates for the KDM4 subfamily20).
For KDM5C, although both the asymmetric and symmetric
dimethylarginine-containing peptides had similar KM values
(KM 29.0±0.5 versus 21.1±5.8 mM), the turnover rate for the
asymmetric peptide was an order of magnitude higher
(41.2 10 3±3.5 10 3 versus 4.6 10 3±0.7 10 3 s 1).
For KDM3A, the monomethylated arginine peptide was a
better substrate than the corresponding dimethylated arginine
peptides (Table 1). These results reflect the MS screening results,
where in the context of overall incomplete substrate peptide
demethylation, only conversion to the unmethylated residue was
observed, that is, no monomethylated peptide intermediate was
detected (Supplementary Fig. 3). Although the monomethylated
arginine-methylated substrate showed a lower kcat value than the
lysine-methylated substrate (11.0±1.2 versus 355±95.3 s 1), the
KM values for all methylated arginine peptides were found to be
smaller than those for H3K9me2 (H3K9Rme¼ 12.1±3.1 mM,
H3K9Rme2a¼ 11.6±1.4 mM, H3K9Rme2s¼ 23.7±1.9 mM and
H3K9me2¼ 44.5±4.8 mM). The kcat value for K9Rme2a and
K9Rme2s were lower than that for K9Rme. The combined kinetic
results described above for each enzyme imply that the relative
efficiency of RDM versus KDM substrate binding and rate of
catalysis is sequence and context-dependent.
RDM activity is observed on ‘natural’ histone peptides. Given
the ability of JmjC enzymes to catalyse demethylation of arginine
residues in synthetic peptide sequences, we were interested to
investigate whether these enzymes could also catalyse arginine
demethylation in ‘natural’ positions in histone peptides. Peptides
representing known methylated arginine sites within the cano-
nical histone tail sequences were synthesized and screened as
substrates for the four enzymes identified as RDMs
(Supplementary Table 1). Interestingly, arginine demethylation
Table 1 | Kinetic parameters for arginine demethylation by KDMs (RDMs).
Enzyme Substrate KM/lM kcat 10 3 s 1 kcat/KM 106
KDM3A H3(1-15)K9me2 44.5±4.8* 355±95.3* 7,978.0
H3(1-15)K9Rme 12.1±3.1 11.0±1.2 907.6
H3(1-15)K9Rme2a 11.6±1.4 5.0±0.6 430.7
H3(1-15)K9Rme2s 23.7±1.9 3.0±0.3 126.5
KDM4E H3(1-15)K9me3 17.8±4.0 170.7±15.2 9,575
H3(1-15)K9Rme2a 66.0±5.0 4.6±0.7 70.4
H3(1-15)K9Rme2s 101.1±11.0 8.7±0.3 85.9
H3(1-15)K9Rme 168.8±35.9 2.7±0.2 15.9
H3(1-15)R2me2a 86.9±16.5 9.9±1.0 114.0
H4(1-15)R3me2a 121.5±10.1 2.1±0.1 17.7
KDM5C H3(1-15)K4me3 7.6±2.9 67.1±10.3 8,800
H3(1-15)K4Rme2a 29.0±0.5 41.2±3.5 1,420.0
H3(1-15)K4Rme2s 21.1±5.8 4.6±0.7 219.0
H3(1-15)R2me2a 19.0±1.9 12.0±0.7 630.0
KDM6B H3(14-34)K27me3 6.7±0.6 11.7±0.1 1,750.0
H3(14-34)K27Rme2a 676.3±118.3 28.8±3.6 42.5
KDM, Ne-methyllysine demethylase; RDM, No-methylarginine demethylase.
Apparent kinetic parameters (KM and kcat values) were determined for each JmjC KDM/RDM using a formaldehyde dehydrogenase-coupled assay. Data show mean±s.e.m (n¼ 3). Recognized histone
Ne-methylated-lysine peptide substrate for each KDM is marked in bold. ‘Natural’ histone peptides are shown in italics.
kcat/KM values are calculated form the average kcat and KM values for each peptide.
* Kinetic parameters calculated using data points below 100mM, substrate inhibition observed above 100 mM.
Table 2 | Summary of observed arginine demethylation activity of tested RDMs.
KDM H3 (1–15) R2X H3 (1–15) R8X H3 (10–24) R17X H3 (18–32) R26X H4 (1–15) R3X
me me2a me2s me me2a me2s me me2a me2s me me2a me2s me me2a me2s
KDM3A               
KDM4E þ þ þ þ þ þ    þ þ þ  þ þ
KDM5C þ þ þ  þ þ        þ 
KDM6B               
þ indicates demethylation activity;  indicates no activity or that below our limits of detection; KDM, Ne-methyllysine demethylase; RDM, No-methylarginine demethylase. X corresponds to
me/me2a/me2s.
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activity on the ‘natural’ histone peptide sequences was observed
for some, but not all of the KDMs (Table 2 and Fig. 4). Both
KDM4E and KDM5C catalysed demethylation of some of the
screened peptides, including peptides methylated at H3R2 and
H4R3 (Fig. 4a,b and Supplementary Figs 8 and 9), while KDM3A
and KDM6B displayed no activity on any of the new peptides
tested (Supplementary Figs 10 and 11). The observation of a lack
of RDM activity for KDM6B with these substrates is notable,
given that KDM6B displayed such high RDM activity with the
unnatural H3K27Rme2a substrate peptide (Table 1). Thus, these
results demonstrate that RDM activity is dependent on the
sequence context.
Further kinetic characterization was carried out on some of the
‘biologically relevant’ peptides identified to be substrates for the
KDMs (Table 1). Interestingly, despite the different neighbouring
peptide sequences to the characterized lysine H3K9me3 substrate
of KDM4E, the H3R2me2a peptide was found to be a
better substrate for KDM4E than H3K9Rme2a or H3K9Rme2s
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Figure 4 | KDMs catalyse arginine demethylation in ‘natural’ histone peptides.MALDI-TOFMS of demethylation of arginine methylated ‘natural’ histone
peptides by (a) KDM4E and (b) KDM5C. (c) MALDI-TOF MS revealing no demethylation activity of KMD4E or KDM5C on a H3(1–15)R2Kme3 peptide.
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(kcat/KM 114.0 10 6 versus 70.4 10 6mM 1 s 1/85.9
10 6mM 1 s 1). The H4R3me2a peptide was a less efficient
substrate for KDM4E, with a turnover rate almost five times
lower than that of the H3R2me2a peptide, similar to that
observed for H3K9Rme. For KDM5C, the H3R2me2a peptide had
a lower KM value than the H3K4Rme2a peptide, but
was an overall slightly less efficient substrate for the enzyme
(kcat/KM 1,420 10 6 versus 630 10 6mM 1 s 1). Never-
theless, with a kcat/KM value only 14 times lower than that for
H3K4me3 it appears possible that this reaction could also occur
in cells in some contexts, particularly if promoted by auxiliary
binding domains or binding partners (as is known to be
important for some JmjC KDM activities (for example, PHF8))24.
Because some JmjC KDMs were found to catalyse demethyla-
tion of methylated arginine peptides in sequences substantially
different from their characterized lysine substrates (for example,
we observed low levels of demethylation of H4R3me2a
(SG-Rme2a-GKGGKGLGKGGAK) by both KDM4E and
KDM5C, Fig. 4), we were interested to see whether substitution
of an arginine residue in the ‘natural’ histone sequence with a
methylated lysine residue would produce a KDM substrate.
Interestingly, despite a peptide containing H3R2me2a being a
relatively good RDM substrate for both KDM4E and KDM5C, the
corresponding H3R2Kme3 peptide (A-Kme3-TKQTARKSTG
GKA) was not observed to be a KDM substrate for either
enzyme within our limits of detection (Fig. 4c). Overall, the
combined results reveal that, at least for some JmjC demethylases,
the preferred sequence contexts can differ for RDM and KDM
activities.
To investigate whether methylarginine demethylation can be
catalysed by full-length JmjC KDMs, as well as by the truncated
constructs, full-length proteins were exogenously overexpressed
in HEK293T cells either as N-terminally Flag-tagged wild-type
proteins or active-site variants known to be catalytically
inactive25–27. The resultant full-length proteins were immuno-
precipitated by their Flag-tags and used in MS assays with
methylated histone peptides. As with the catalytic domain
constructs, arginine demethylation was also observed with all
four of the full-length proteins (KDM3A, KDM4A, KDM5C and
KDM6B; note KDM4A was used in place of KDM4E as KDM4E
is a pseudogene) tested on both ‘unnatural’ and ‘natural’ peptide
substrates (Fig. 5 and Supplementary Figs 12–16). No RDM
activity was observed with the catalytically inactive enzyme
variants. Note that, with KDM3A, arginine demethylation activity
was observed for the monomethylated peptides, but not for the
symmetrically or asymmetrically methylated peptides; this result
is consistent with the observed relative reaction efficiencies of
these peptides with the truncated construct (Supplementary Fig
13 and Table 1).
JmjC enzymes bind arginine and lysine in a similar manner.
Crystallographic studies were then undertaken to investigate the
binding modes of methylarginine-containing peptides with JmjC
enzymes. KDM4A, a close structural homologue of KDM4E that
can also catalyse demethylation of methylarginine peptides (albeit
less efficiently in our current assays, Fig. 5), was selected for the
crystallographic work because of its relatively robust
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Figure 5 | Full-length (FL) KDMs catalyse demethylation of arginine residues. MALDI-TOF MS of demethylation of arginine methylated peptides by
Flag-tagged FL KDMs immunoprecipitated from HEK293T cells.
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crystallization properties and because it has previously been
crystallized with Ne-methylated lysine peptide substrates20,28–30.
A suitable crystal was obtained using KDM4A and an H4R3me2s
fragment sequence (residues 1–15) with nickel substituting for
iron and N-oxalylglycine (NOG) acting as a 2OG mimetic). The
structure was solved by molecular replacement using PDB ID:
2OX0 as the search model; two molecules of KDM4A (chains A
and B) are present in the asymmetric unit. In the initial electron
density maps, other than for the methylated arginine itself, only
weak difference in electron densities were observed for residues in
the substrate peptide, suggesting that the mode of methylated
arginine peptide binding could be flexible. We generated an
Fo–Fc OMIT map (where different densities were calculated
omitting H4R3me2s) as a guide to locate any unmodelled
difference peak around the KDM4A (A/B) active sites. This
unweighted omit map revealed more than one likely
conformation of the methylated arginine side chains and traces
of H4R3me2s peptide backbones; only major conformations were
modelled and refined in the final structure.
Although care should be taken in over-interpreting ‘static’
crystal structures of substrate fragments, it is of interest that the
arginine side chain was observed to adopt two different extended
conformations after refinement. One orientation positions one of
the methyl groups of the symmetrically dimethylated arginine
residue sufficiently close to the metal centre to enable catalysis
(within 4.5 Å; Fig. 6a). The other side chain orientation is a likely
catalytically unproductive conformation, wherein the side chain is
oriented away from the metal (Fig. 6b; for overlay, see Fig. 6c).
The presence of such an unproductive binding conformation
might in part account for the higher degree of uncoupled 2OG
turnover stimulated by methylated arginine compared with
methylated lysine peptide binding, as observed for KDM6B with
H3(14–34)K27Rme2a (for overlay of arginine and lysine binding,
see Fig. 6d).
Potential for JmjC RDM activity on non-histone substrates.
Arginine methylation has been reported for numerous non-
histone proteins, as observed by antibody- and/or MS-based
approaches, where it is proposed to regulate many cellular
processes including alteration of cellular localization, protein
stability and protein–protein/DNA interactions31,32. Although
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Figure 6 | JmjC KDMs bind methylated arginine peptides in a catalytically-productive binding mode. (a and b) Views from an X-ray crystal structure of
KDM4A in complex with nickel, NOG (a 2OG mimetic) and an H4R3me2s peptide (residues 1–15). Two orientations of peptide binding were refined; one
orientation (a) positions a methyl group of symmetric dimethylarginine residue sufficiently close to the metal centre to allow catalysis (within 4.5Å, for
crystallographic reasons, nickel was substituted for iron). The other orientation (b) is likely not catalytically productive. Fo-Fc OMIT maps contoured to 3s
around the H4R3me2s residues are shown. (c) Overlay of the two binding orientations observed for the H4R3me2s peptide in the KDM4A active site. Only
one orientation (blue) positions a methyl group close to the catalytic metal centre. (d) Overlay of the H4R3me2s peptide (catalytically-productive
orientation only) and an H3K9me3 peptide (residues 7–14) bound in the KDM4A active site. The methylated arginine and lysine residues show similar
binding modes.
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limited at present, there are some reports providing at
least preliminary evidence for non-histone protein lysine
demethylation catalysed by JmjC KDMs33–35. Given the ability
of the JmjC KDMs to act as RDMs for peptides with sequences
substantially different from their characterized lysine sequences,
we were interested to investigate whether removal of non-histone
arginine methylation could also be catalysed by 2OG oxygenases.
As KDM6B is known to interact with tumour protein p53 (p53),
peptide sequences containing known arginine methylation sites
were synthesized and tested as JmjC RDM substrates36; however,
no demethylation was observed (Fig. 7 and Supplementary
Fig. 17). A selection of peptides from some other nuclear proteins
known to be abundantly methylated on arginine residues were
also synthesized and tested as RDM substrates by MS. While the
majority of these peptides were found not to be substrates, in
some cases clear arginine demethylation was observed (Fig. 7 and
Supplementary Fig. 17). Demethylation of asymmetric dimethy-
lated arginine residues within peptides from heterogeneous
nuclear ribonucleoprotein K (hnRNP K) and tumour
suppressor p53-binding protein 1 (53BP1) was observed, as
catalysed by KDM4E and KDM5C, respectively. If replicable in
cells, these results raise the possibility that arginine demethylation
could be a widespread phenomenon extending well beyond the
canonical histone tails.
Discussion
Since the observation of Ne-lysine methylation in 1959 (ref. 37),
multiple protein residues have been found to undergo N- and
O-methylation31,38. Within the context of gene regulation, the
N-methylation of lysine and arginine residues on histone tails
plays critical roles. Multiple methyltransferases have been
identified, many of which are apparently highly promiscuous,
acting to catalyse methylation on numerous proteins31,33,39,40.
Despite the pioneering observations in 1973 of the oxidative
demethylation of Ne-methylated lysine residues in calf thymus
histones41, the identification of the sequences of Ne-methyl-group
demethylases took three decades. Following the identification of
KDM1A in 2004 (ref. 42), the subsequent discovery of the JmjC
KDMs validated the early studies in identifying oxygenases that
catalyse Ne-methyllysine demethylation to release formal-
dehyde4,43,44. Given the plethora of methylated proteins, it
appears possible that some KDMs might be found to be equally
promiscuous as KMTs.
The possibility of RDM activities related to those of the KDMs
is readily envisaged. While no lysine-specific demethylase-type
flavin-dependent RDMs have been reported (although are
feasible), the JmjC oxygenase JMJD6 has been reported as an
RDM acting on histones and other non-histone proteins9,15,16.
However, in our laboratory’s work with JMJD6 we have observed
only lysine hydroxylation, not RDM activity10,45. Various reports
have appeared in the recent literature describing both
hydroxylation and RDM activities for JMJD6 (refs 13–17,46).
Other JmjC oxygenases have also been the subject of controversial
assignments47–49. In most cases the cell-based work has
principally employed antibody-based methods, in some cases
supported by ‘proteomic’ MS evidence, and at present
biochemical evidence for the RDM activity of JMJD6 remains
limited. Identification of both RDM and KDM activities in a
cellular context using antibodies can be complicated by
difficulties in accurately quantifying absolute levels of both
methylated substrates and the demethylated products and (along
with other factors) by a lack of appropriately specific antibodies
for substrates and products50. MS-based methods, while rapidly
improving, are also not normally sufficiently well optimized for
measuring absolute levels in cells, particularly for low abundance
post-translational modifications32,50–52. Thus, while we
appreciate that enzyme activity may differ in the isolated
protein form from cellular contexts (for example, as observed
for the 2OG-dependent protein hydroxylase factor inhibiting
hypoxia-inducible factor53), given the complexity and
controversy in JmjC assignments, in particular, in the arginine
demethylation field, we believe that, where possible, it is
important to define the ‘biochemical reactions’ catalysed by
potential RDMs (and KDMs) using isolated enzymes.
The assays applied here directly measure, either by mass shifts
or by the appearance of new NMR signals, the product(s) of
KDM/RDM activity. It should be noted that in the context of MS
analyses we undertook to carry out careful non-enzyme controls
to ensure that the conditions of MS analysis did not invoke
apparent demethylation, or that we were not observing
contamination of the putative product in the starting material,
which might not be apparent before incubation.
The results clearly show that, at least under our assay
conditions, some, but not all, recombinant forms of JmjC KDMs
do have RDM activity. Thus, we observed that KDM3A, KDM4E,
KDM5C and KDM6B can catalyse demethylation of methylated
arginine residues when substituted for the methylated lysine
residue in their characterized peptide substrates. In addition,
KDM4E (and full-length KDM4A) and KDM5C were found to
catalyse demethylation of histone peptides methylated at H3R2,
H3R8, H3R26 (KDM4E, but not KDM5C) and H4R3, and also
some non-histone peptide sequences.
One interesting result to emerge from the studies on both
histone and non-histone RDM and KDM substrates for the JmjC
enzymes is that the apparent sequence selectivities can differ for
RDM and KDM activities, even with the same enzyme. Thus, for
example, H3R2me2a is a better substrate for KDM4E than
H3K9Rme2a (Table 1), and the analogous H3R2Kme3 peptide is
not a substrate for KDM4E or KDM5C (Fig. 4c). Although the
biological significance of these results is presently unclear, they
can be rationalized by the likelihood that in order for productive
demethylation to occur, the methylarginine and methyllysine side
chains are likely accommodated differently by dual-function
KDM/RDM enzymes in order to ensure a catalytically productive
relationship between the reactive Fe(IV)¼O intermediate and
the methyl group at the active site. The differential orientation of
the lysine and arginine side chains may in turn have ‘knock-on’
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Figure 7 | KDMs catalyse demethylation of arginine residues in non-histone substrates. MALDI-TOF MS assays for demethylation of non-histone
arginine methylated peptides by KDMs. Red spectra show reactions including enzyme and black spectra the no-enzyme controls.
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effects with respect to optimal binding of the surrounding
substrate residues. Support for this proposal comes from work
revealing that in the case of KDM4A-C, aside from the
methylated lysine residues, the H3K9 and H3K36 substrates are
accommodated differently at the entrance to the active site30,54.
Given that for some KDMs post-translational modifications
distinct from the residue undergoing demethylation can
substantially promote activity, it is possible that RDM activity is
similarly promoted. The partial decoupling of 2OG oxidation and
demethylation observed for some RDM substrates may reflect
non-optimal substrate sequences, or use of a truncated
substrate, as precedented with other 2OG-dependent protein
hydroxylases55. However, it is important to note that, at least in
the case of KDM6B, some of the RDM activities we observe are of
similar levels to the KDM activity, implying the likelihood of
biological relevance of the dual-function KDM/RDM results in
some situations (including by competition between substrates).
We appreciate that further work is required on protein
substrates in cells for the full biological relevance of these results
to be established. Despite considerable efforts, we are not yet able
to conclusively determine RDM activity in cells, in part because of
the lack of suitably useful antibodies. Nonetheless, the biochem-
ical assignment of RDM activity is interesting and relevant to
future work on the functional studies on JmjC enzymes in cells.
The JmjC KDMs have been linked to a plethora of human
developmental diseases and cancers, and there is growing interest
in them as pharmaceutical targets56–58. In addition to helping to
elucidate the regulatory mechanisms involved in arginine
methylation cycles, these results reveal new enzymatic activity
and function of the JmjC KDMs, an understanding of which may
be crucial to their effective therapeutic targeting. In this regard, it
is important to note that, at least some of the roles of JmjC KDMs
in disease may involve their production of formaldehyde, which is
a product of both KDM and RDM catalysis, and which, at least
above threshold levels, is toxic59. Now that enzymes that have
RDM activity have been conclusively identified, efforts can focus
on the demonstration of their biological relevance.
Methods
Materials. Full-length Flag-tagged KDMs were expressed in HEK293T cells
(ATCC) using plasmids encoding full-length KDM4A1–1,064 (ref. 26), H188A
KDM4A1–1,064 (ref. 26), KDM6B1–1,636 (ref. 27), H1390A KDM6B1–1,636 (ref. 27),
KDM3A1–1,321 (ref. 25) and H1120Y KDM3A1–1,321 (ref. 25) as described
previously. Plasmids encoding Flag-tagged KDM5C1–4,680 and H513A/E515A
KDM5C1–4,680 were kindly provided by Pavel Savitsky (Structural Genomics
Consortium, Oxford). Recombinant constructs of KDM2A1–557 (ref. 60),
KDM4A1–359 (ref. 30), KDM4E1–337 (ref. 61), KDM6B1,141–1,590 (ref. 62) and
PHF81–447 (ref. 63) were produced as N-terminally His6-tagged proteins
in Escherichia coli cells. KDM3A515–1,317 was produced as an N-terminally
His6-tagged protein in Sf9 cells62. KDM5C1–765 was produced as an N-terminally
His6-tagged protein in Sf9 cells and was kindly provided by Aleksandra Szykowska
(Structural Genomics Consortium). Proteins were purified by Ni-affinity
chromatography and size exclusion chromatography as previously described.
Peptide synthesis. Peptides were produced in house using a Liberty Blue
automated microwave peptide synthesizer (CEM Corporation) for kinetic and
crystallographic studies or either a Multipep RSi (Intavis Bioanalytical Instruments
AG) or an S336X peptide synthesizer (CS Bio) for screening purposes. Fluor-
enylmethyloxycarbonyl-mediated solid-phase chemistry (on MBHA resin) was
used to produce the peptides with C-terminal amides. After synthesis, peptides
were cleaved from the resin by incubation with 92.5% trifluoroacetic acid/2.5%
water/2.5% triisopropylsilane/2.5% dimethoxybenzene (3 h) followed by pre-
cipitation with ice-cold diethyl ether. Lyophilized peptides produced on the Liberty
Blue or S336X synthesizers were purified by reverse-phase high-performance liquid
chromatography using a Vydac C18 column (Solvent A¼ 0.1% trifluoroacetic acid
in H2O, Solvent B¼ 0.1% trifluoroacetic acid in acetonitrile) to 495% purity as
determined by MS. Peptides used for screening were assayed unpurified. Peptide
sequences are given in Supplementary Table 1. Methylated arginines suitably
protected for solid-phase peptide synthesis were purchased from Novabiochem. In
all cases the observed masses for peptides were within 2Da of the predicted values
by MALDI MS.
Activity assays. MALDI MS activity assays. Recombinant proteins (2mM) were
incubated with peptides (10 mM, sequences are given in Supplementary Table 1)
and cofactors/substrates for 1 h at 37 C, unless otherwise specified. Reactions were
quenched with 1:1 (v/v) methanol and analysed with MALDI MS. Assay conditions
for each enzyme are given in Supplementary Table 2. Negative controls without
enzyme were included. Note that in some cases small variations (r2Da) in the
absolute experimentally observed values compared with the calculated values for
peptides were observed. However, in all cases where demethylation is assigned the
mass shift was 14Da.
Formaldehyde dehydrogenase-coupled assays. Preliminary kinetic parameters
were determined by detection of the formaldehyde by-product of the
demethylation reaction using a FDH (formaldehyde dehydrogenase-coupled)/
NADþ -coupled assay as previously described61. Assays were carried out in buffer
(enzyme-dependent) with the addition of Fe(II) ammonium sulfate (10 mM),
sodium ascorbate (100 mM), 2OG (200 mM), NADþ (500 mM), enzyme (0.2–4 mM)
and FDH enzyme (0.025U per assay, Sigma-Aldrich; total volume 30 ml) and were
conducted at 37 C in clear-bottom black 384-well plates. Reactions were
monitored over 25min using a PHERAstar FS (BMG Labtech) plate reader with
355 nm excitation and 460 nm emission. The Km and Vmax values were calculated
from the reaction rate during the linear phase of formaldehyde production, as
determined by the slope of the fluorescence signal recorded.
NMR assays. NMR spectroscopy was carried out as described22. NMR spectra
were recorded using a Bruker Avance AVIII 700MHz spectrometer equipped with
an inverse TCI cryoprobe, optimized for 1H observation and installed with the
Topspin software. All samples were prepared in Eppendorf tubes (75 ml volume)
before being transferred to 2-mm MATCH NMR tubes (Wilgenberg); time course
data were then collected over a period of 20min at 89-s intervals using an
automated routine. The solvent deuterium signal was used as an internal lock
signal, and the solvent signal was reduced by excitation sculpting64. Enzyme stocks
were in protiated HEPES/NaCl buffer, pH 7.5, which was diluted with dAFN buffer
(prepared by diluting 500mM ammonium formate, 5M NaCl in H20 pH 7.5 to
10% v/v in D2O) when added to the samples. Chemical shifts are reported relative
to the solvent water resonance (dH 4.7 p.p.m.).
Cell culture. HEK293T cells (ATCC) were cultured at 37 C and 5% CO2 in high-
glucose DMEM (Sigma) supplemented with 10% fetal bovine serum (Sigma) and
1% Glutamax (Sigma). Full-length KDMs with Flag-tags were transiently trans-
fected into HEK293T cells using linear polyethylenimine (PEI) (10mg DNA, 60ml
PEI per T75, 60% confluency, PAA Laboratories) and were harvested after 24–48 h.
On-bead demethylation assays. Cells transiently transfected with the relevant
KDM were washed in PBS buffer and lysed in 50mM HEPES, pH 7.5, 150mM
NaCl, 0.5% NP40, 1% EDTA-free protease inhibitor cocktail and DNAse
(10 mgml 1). Lysate was diluted fivefold with buffer containing 50mM HEPES,
pH 7.5, 150mM NaCl before being incubated with 20 ml anti-FLAG M2 Magnetic
Beads (Sigma-Aldrich) for 3 h at 4 C. Beads were washed four times with lysis
buffer (500 ml) and two times with 50mM HEPES (500 ml; or 50mM HEPES,
150mM NaCl where NaCl was used in the reaction buffer) before MS analysis.
Beads were resuspended in a final volume of 30 ml for use in activity assays.
Demethylation reactions were conducted with 2 ml of the immobilized anti-
FLAG bead suspension with peptide (10 mM) and cofactors/substrates (conditions
given in Supplementary Table 3). Reactions were incubated for 3 h at 37 C and
quenched with 1:1 MeOH by volume. The demethylation products were detected
by MALDI MS. Western blotting of lysate samples was carried out to confirm
exogenous overexpression of all enzymes using mouse anti-Flag primary (F3165
Sigma, 1:1,000, overnight, 4 C) and goat anti-mouse-HRP (W4021 Promega,
1:10,000, 1 h, room temperature, Supplementary Fig. 12).
Crystallization. Co-crystals of KDM4A1–359.Ni(II).H4(1–15)R3me2s.NOG were
obtained in sitting drops grown at 4 C. Drops contained 10mgml 1 KDM4A,
5mM H4(1–15)R3me2s, 5mM NOG and 4mM NiCl2. Crystals were cryoprotected
with 25% glycerol before being flash-frozen in liquid N2. Data were collected using
a single crystal at 100 K at the Diamond I04-1 MX beam line and were processed
with HKL2000 (ref. 65). The structure was solved by molecular replacement using
PHASER66 (search model PDB ID 2OX0) and was refined by alternative cycles
of CNS67 and PHENIX68, with iterative rebuilding of the refined model using
COOT69. All residues were in the allowed regions of the Ramachandran plot as
calculated by PROCHECK70. Data collection and refinement statistics are given in
Supplementary Table 4. A stereo image of a portion of the electron density map is
shown in Supplementary Fig. 18.
Statistical analysis. Each result shows the mean of three independent experi-
ments with error bars representing the s.e.m. Each experiment was carried out
(at least) in technical triplicate.
Data availability. The data that support the findings of this study are available
from the corresponding author upon request. The crystal structure has been
deposited under PDB accession code 5FWE.
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